Checkpoint Inhibitor Immunotherapy Toxicity and Overall Survival among Older Adults with Advanced Cancer

OBJECTIVES: Despite growing evidence that checkpoint inhibitor immunotherapy (IO) toxicity is associated with improved treatment response, the relationship between immune-related adverse events (irAEs) and overall survival (OS) among older adults [age ≥ 70 years (y)] remains unknown. The study goal...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Geriatr Oncol
Hlavní autoři: Johns, Andrew C., Wei, Lai, Grogan, Madison, Hoyd, Rebecca, Bridges, John F.P., Patel, Sandipkumar H., Li, Mingjia, Husain, Marium, Kendra, Kari L., Otterson, Gregory A., Burkart, Jarred T., Rosko, Ashley E., Andersen, Barbara L., Carbone, David P., Owen, Dwight H., Spakowicz, Daniel J., Presley, Carolyn J.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2021
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC8184608/
https://ncbi.nlm.nih.gov/pubmed/33627226
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.jgo.2021.02.002
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky